Breast carcinoma cells treated with PPARγ agonist show dramatic morphological changes, and express E-cadherin and b-casein, markers of breast cell differentiation (Elstner et al, 1998; Clay et al, 1999). This evidence concerns the gene PPARG and breast carcinoma.